Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor
Clinical trial NCT01985256 · COMPLETED
Trial details
- NCT number
- NCT01985256
- Sponsor
- Tocagen Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2016-03-03
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.